Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Abstract Natural killer (NK) cells play a crucial role in host immunity by detecting cells that downregulate MHC class I presentation and upregulate stress ligands, as commonly seen in cancers. Current NK therapies using primary NK cells are prone to manufacturing issues related to expansion and sto...
Main Authors: | Keerthana Shankar, Christian M. Capitini, Krishanu Saha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-020-01741-4 |
Similar Items
-
The Cutting Edge of Disease Modeling: Synergy of Induced Pluripotent Stem Cell Technology and Genetically Encoded Biosensors
by: Kamila R. Valetdinova, et al.
Published: (2021-08-01) -
Improvement of the knock-in effciency in the genome of human induced pluripotent stem cells using the CRISPR/Cas9 system
by: М. М. Gridina
Published: (2019-01-01) -
Optimization of Methods for Generating Customized Gene-Edited Human Pluripotent Stem Cells
by: Campbell, Ian
Published: (2017) -
In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation
by: Kuo-Hsuan Chang, et al.
Published: (2021-09-01) -
A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells
by: Chloe L. Christensen, et al.
Published: (2017-02-01)